Shreeyashi Ojha | BioProcess International

Shreeyashi Ojha

Reporter, BioProcess Insider

Journalist covering the manufacturing and processing sectors for biopharmaceuticals globally.

Originally from India, I am a Londoner at heart. I have recently graduated from Goldsmiths, University of London.

Feel free to reach out to me at: [email protected].

Latest from Shreeyashi Ojha

SK pharmteco secures $1.4bn GLP-1 deal SK pharmteco secures $1.4bn GLP-1 deal

byShreeyashi Ojha

Dec 19, 2024

2 Min Read

Novo Catalent deal clears regulatory hurdles Novo Catalent deal clears regulatory hurdles

byShreeyashi Ojha

Dec 16, 2024

2 Min Read

All from Shreeyashi Ojha

Asahi strengthens autoimmune focus with Chiome partnership

Asahi strengthens autoimmune focus with Chiome partnership

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel

Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel

byShreeyashi Ojha, Reporter

Facilities & Capacity

Diabetes drug firms Sanofi, Novo expand global footprint

Diabetes drug firms Sanofi, Novo expand global footprint

byShreeyashi Ojha, Reporter

Facilities & Capacity

BioMarin bolsters Ireland footprint with $63m expansion

BioMarin bolsters Ireland footprint with $63m expansion

byShreeyashi Ojha, Reporter

Therapeutic Class

Is India reliable? Addressing challenges in the pharma industry

Is India reliable? Addressing challenges in the pharma industry

byShreeyashi Ojha, Reporter

Facilities & Capacity

Novo expands EU footprint with $200m Novavax plant

Novo expands EU footprint with $200m Novavax plant

byShreeyashi Ojha, Reporter

Therapeutic Class

India’s pharma future relies on regulatory strength

India’s pharma future relies on regulatory strength

byShreeyashi Ojha, Reporter

Facilities & Capacity

Sanofi opens AI-powered $595m facility in Singapore

Sanofi opens AI-powered $595m facility in Singapore

byShreeyashi Ojha, Reporter

Facilities & Capacity

Lonza doubles bioconjugation capacity at Swiss facility

Lonza doubles bioconjugation capacity at Swiss facility

byShreeyashi Ojha, Reporter

Facilities & Capacity

Cytiva strengthens APAC presence with Korea plant

Cytiva strengthens APAC presence with Korea plant

byShreeyashi Ojha, Reporter

Therapeutic Class

Repligen credits 10% revenue surge to new modalities and M&As

Repligen credits 10% revenue surge to new modalities and M&As

byShreeyashi Ojha, Reporter

Novo taps Ascendis in $285m GLP-1 deal

Novo taps Ascendis in $285m GLP-1 deal

byShreeyashi Ojha, Reporter

Facilities & Capacity

AmplifyBio bolsters Ohio plant with $50m backing from Vitrian

AmplifyBio bolsters Ohio plant with $50m backing from Vitrian

byShreeyashi Ojha, Reporter

Therapeutic Class

Post-pandemic dip: Panelists discuss CGT challenges

Post-pandemic dip: Panelists discuss CGT challenges

byShreeyashi Ojha, Reporter

Facilities & Capacity

Thermo Fisher expands India footprint with bioprocess design center

Thermo Fisher expands India footprint with bioprocess design center

byShreeyashi Ojha, Reporter

Facilities & Capacity

Sterling doubles ADC capacity at UK facility

Sterling doubles ADC capacity at UK facility

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ardena bolsters bioanalytical capacity with Netherlands lab construction

Ardena bolsters bioanalytical capacity with Netherlands lab construction

byShreeyashi Ojha, Reporter

Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability

Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability

byShreeyashi Ojha, Reporter

Facilities & Capacity

MilliporeSigma bolsters ADC business with $76m US expansion

MilliporeSigma bolsters ADC business with $76m US expansion

byShreeyashi Ojha, Reporter

Facilities & Capacity

Celltechna opens $54m gene therapy center in Lithuania

Celltechna opens $54m gene therapy center in Lithuania

byShreeyashi Ojha, Reporter

Facilities & Capacity

Rentschler bolsters production with 3,400 square-meter expansion

Rentschler bolsters production with 3,400 square-meter expansion

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ins & Outs: Forge, Veranova, Cellipont announce C-suite rejigs

Ins & Outs: Forge, Veranova, Cellipont announce C-suite rejigs

byShreeyashi Ojha, Reporter

Therapeutic Class

Investors prioritize efficacy in the CGT biz, experts say

Investors prioritize efficacy in the CGT biz, experts say

byShreeyashi Ojha, Reporter

Facilities & Capacity

CDMO AGC places CO plant on ice amid turbulent CGT economy

CDMO AGC places CO plant on ice amid turbulent CGT economy

byShreeyashi Ojha, Reporter

Therapeutic Class

USPs and efficacy driving CGT competitiveness

USPs and efficacy driving CGT competitiveness

byShreeyashi Ojha, Reporter

Facilities & Capacity

Amgen to divest ex-Horizon aseptic plant by 2026

Amgen to divest ex-Horizon aseptic plant by 2026

byShreeyashi Ojha, Reporter

Facilities & Capacity

Now open: Millipore’s Maryland facility slashes virus testing time

Now open: Millipore’s Maryland facility slashes virus testing time

byShreeyashi Ojha, Reporter

Recipharm and Exela collaborate to boost US sterile injectable production

Recipharm and Exela collaborate to boost US sterile injectable production

byShreeyashi Ojha, Reporter

Xcellbio and AmplifyBio partner to advance cell-therapy development

Xcellbio and AmplifyBio partner to advance cell-therapy development

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ferring bolsters Adstiladrin production with Finland expansion

Ferring bolsters Adstiladrin production with Finland expansion

byShreeyashi Ojha, Reporter

Facilities & Capacity

Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity

Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ins & Outs: Leadership shuffles at CDMOs

Ins & Outs: Leadership shuffles at CDMOs

byShreeyashi Ojha, Reporter

Legend Bio and Multiply Labs partner to improve CAR-T manufacturing

Legend Bio and Multiply Labs partner to improve CAR-T manufacturing

byShreeyashi Ojha, Reporter